Protagonist Therapeutics Inc (NASDAQ:PTGX)
| 28.11 Delayed Data As of Jan 28 |  +1.73 / +6.56%Today’s Change | 12.80 Today|||52-Week Range 50.54 | -17.81% Year-to-Date |
Latest PTGX News | Press Releases
No recent news for Protagonist Therapeutics Inc.
Today’s Trading
| Previous close | 26.38 |
| Today’s open | 26.01 |
| Day’s range | 26.01 - 28.15 |
| Volume | 46,218 |
| Average volume (3 months) | 1,357,730 |
| Market cap | $1.4B |
Data as of 4:00pm ET, 01/28/2022
Growth & Valuation
| Earnings growth (last year) | +35.48% |
| Earnings growth (this year) | -40.25% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +12,293.07% |
| P/E ratio | NM |
| Price/Sales | 24.22 |
| Price/Book | 4.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ATRAAtara Biotherapeutic... | +0.58 | +4.07% |
| BCYCBicycle Therapeutics... | +1.11 | +2.40% |
| NSTGNanoString Technolog... | +1.26 | +4.06% |
| ALECAlector Inc | +0.55 | +3.90% |
Data as of 4:00pm ET, 01/28/2022
Financials
| Next reporting date | March 9, 2022 |
| EPS forecast (this quarter) | -$0.76 |
| Annual revenue (last year) | $28.6M |
| Annual profit (last year) | -$66.2M |
| Net profit margin | -231.07% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newark, California |
Forecasts
